Heat shock protein 27 (HSP27) accumulates in stressed cells and helps them to survive adverse conditions. We have already shown that HSP27 has a function in the ubiquitination process that is modulated by its oligomerization/phosphorylation status. Here, we show that HSP27 is also involved in protein sumoylation, a ubiquitinationrelated process. HSP27 increases the number of cell proteins modified by small ubiquitin-like modifier (SUMO)-2/3 but this effect shows some selectivity as it neither affects all proteins nor concerns SUMO-1. Moreover, no such alteration in SUMO-2/3 conjugation is achievable by another HSP, such as HSP70. Heat shock factor 1 (HSF1), a transcription factor responsible for HSP expression, is one of the targets of HSP27. In stressed cells, HSP27 enters the nucleus and, in the form of large oligomers, binds to HSF1 and induces its modification by SUMO-2/3 on lysine 298. HSP27-induced HSF1 modification by SUMO-2/3 takes place downstream of the transcription factor phosphorylation on S303 and S307 and does not affect its DNA-binding ability. In contrast, this modification blocks HSF1 transactivation capacity. These data show that HSP27 exerts a feedback inhibition of HSF1 transactivation and enlighten the strictly regulated interplay between HSPs and HSF1. As we also show that HSP27 binds to the SUMO-E2-conjugating enzyme, Ubc9, our study raises the possibility that HSP27 may act as a SUMO-E3 ligase specific for SUMO-2/3.
Heat shock protein 27 (HSP27) accumulates in stressed cells and helps them to survive adverse conditions. We have already shown that HSP27 has a function in the ubiquitination process that is modulated by its oligomerization/phosphorylation status. Here, we show that HSP27 is also involved in protein sumoylation, a ubiquitinationrelated process. HSP27 increases the number of cell proteins modified by small ubiquitin-like modifier (SUMO)-2/3 but this effect shows some selectivity as it neither affects all proteins nor concerns SUMO-1. Moreover, no such alteration in SUMO-2/3 conjugation is achievable by another HSP, such as HSP70. Heat shock factor 1 (HSF1), a transcription factor responsible for HSP expression, is one of the targets of HSP27. In stressed cells, HSP27 enters the nucleus and, in the form of large oligomers, binds to HSF1 and induces its modification by SUMO-2/3 on lysine 298. HSP27-induced HSF1 modification by SUMO-2/3 takes place downstream of the transcription factor phosphorylation on S303 and S307 and does not affect its DNA-binding ability. In contrast, this modification blocks HSF1 transactivation capacity. These data show that HSP27 exerts a feedback inhibition of HSF1 transactivation and enlighten the strictly regulated interplay between HSPs and HSF1. As we also show that HSP27 binds to the SUMO-E2-conjugating enzyme, Ubc9, our study raises the possibility that HSP27 may act as a
Introduction
Stress or heat shock proteins (HSPs) are induced by different stresses and help the cells to cope with these otherwise lethal conditions. This stress response is universal and is very well conserved through evolution. Two of the most stress-inducible HSPs are HSP70 and HSP27. Although HSP70 is an ATP-dependent chaperone induced early after stress and is involved in the correct folding of proteins, HSP27 is a late inducible HSP whose main chaperone activity is to inhibit protein aggregation in an ATP-independent manner . HSP27 has the ability to form oligomers of up to 1000 kDa. HSP27 oligomerization is a highly dynamic process modulated by the phosphorylation of the protein. Human HSP27 can be phosphorylated on three serines (S15, S78 and S82) and the phosphorylation provokes a shift toward small oligomers (Lambert et al., 1999; Rogalla et al., 1999) . The different activities of HSP27 seem to be modulated by the oligomerization pattern of the chaperone. We have shown, in vitro and in vivo, that large non-phosphorylated oligomers of HSP27 are responsible for the caspase-dependent antiapoptotic effect of this chaperone (Bruey et al., 2000) . Other groups have shown that large oligomers are needed for HSP27 antioxidant activity (Rogalla et al., 1999) . Large non-phosphorylated HSP27 oligomers bind to actin and the two proteins dissociate upon HSP27 phosphorylation (During et al., 2007) . In contrast, it is proven that phosphorylated HSP27 directly interacts with Daxx (Charette et al., 2000) . Moreover, small oligomers of HSP27 are also the form of the protein, which displays affinity for ubiquitin chains and accelerates the degradation of certain proteins under stress conditions . These results suggest that oligomerization/phosphorylation of the protein alters HSP27 conformation and, hence, determines its capacity to interact with its different partners.
Expression of HSP genes is regulated by the family of the heat shock transcription factors, which bind to the heat shock element (HSE) in the promoter region of heat shock genes and, thereby stimulate their transcription. Three members have been identified in mammals, of which heat shock factor 1 (HSF1) is the major stressresponsive family member as no other HSF is able to functionally substitute for HSF1 or to rescue the heat shock response in HSF1-deficient cells or mice (McMillan et al., 1998; Xiao et al., 1999) . In response to stressful stimuli such as elevated temperatures, oxidants, heavy metals, and bacterial or viral infections, HSF1 is activated by trimerization and hyperphosphorylation (Pirkkala et al., 2001; Holmberg et al., 2002) . As a result, HSF1 acquires the ability to bind to HSE and to activate transcription of heat shock genes, which results in accumulation of HSPs such as HSP27 and HSP70 with, as a final outcome, cell protection (Pirkkala et al., 2001; Didelot et al., 2006; Garrido et al., 2006; Schmitt et al., 2007; Anckar and Sistonen, 2007a, b) . Once the stress conditions are over, HSP gene transcription must immediately stop. HSF1 activity is therefore tightly regulated, in particular, through various types of posttranslational modifications. Thus, HSF1 can be phosphorylated at different serine residues (Holmberg et al., 2001 (Holmberg et al., , 2002 and be ubiquitinated (Lee et al., 2008) . More recently, it has been shown that HSF1 can also be sumoylated (Hong et al., 2001; Hietakangas et al., 2003 Hietakangas et al., , 2006 Anckar et al., 2006) .
Small ubiquitin-like modifier (SUMO) proteins are about 100 amino acids in size with a three-dimensional structure reminiscent to that of ubiquitin. However, SUMO and ubiquitin share o20% amino acid sequence identity and are different in their overall surface charge distribution (Geiss-Friedlander and Melchior, 2007) . Like ubiquitination, sumoylation results in the formation of an isopeptide bond between the glycine residue of the modifier protein and the e-amino group of a lysine residue in the acceptor protein. SUMO conjugation utilizes a multistep enzymatic pathway, in which proteolytically processed SUMO initially forms a thioester bond with Sae1/2, the E1 SUMO-activating enzyme (Johnson, 2004) . The SUMO moiety is subsequently transferred to Ubc9, the single E2 SUMOconjugating enzyme, which usually binds directly the target protein at the level of sumoylated sites (GeissFriedlander and Melchior, 2007) . E2-substrate interaction may be facilitated by SUMO-E3 factors. The E3 factors increase sumoylation efficiency in a substratespecific manner, either by accelerating the transfer of SUMO from Ubc9 to the substrate or merely by providing a scaffold (Guo et al., 2005; Geiss-Friedlander and Melchior, 2007) . The SUMO family consists of four members, SUMO-1, -2, -3 and -4, but SUMO-4 has only been detected at the RNA level (Guo et al., 2005; GeissFriedlander and Melchior, 2007) . SUMO-2 and -3 are 97% identical to each other and, therefore, they cannot be differentiated at the protein level (Saitoh and Hinchey, 2000) . SUMO-1 and SUMO-2/3 although ubiquitously present in mammals, have, at least partially, distinct substrates and regulation (Saitoh and Hinchey, 2000; Zhu et al., 2008) . The expression of SUMO-2/3 in contrast to that of SUMO-1 increases after different stresses (Saitoh and Hinchey, 2000; Ayaydin and Dasso, 2004) . Beyond this, the functional differences between the SUMO paralogues are largely unknown. In most cases, sumoylation results in the addition of single SUMO entities. Sumoylation can cause changes in protein-protein interactions, subnuclear localization and conformational changes (Gill, 2003; Hay, 2005) . Many transcription factors such as HSF1 have been shown to be sumoylated and this modification, in most cases, impairs the transactivation capacity of the substrate (Geiss-Friedlander and Melchior, 2007) .
Heat shock factor 1 has been shown to undergo stressinducible SUMO-2/3 modification on a conserved lysine, K298 (Hietakangas et al., 2003) . Further, it has been shown that HSF1 has to be previously phosphorylated on serine 303 for its subsequent sumoylation (Hietakangas et al., 2003) . Considering the need of regulated chaperone levels in maintaining cellular homoeostasis, repression of HSF1 activity by interaction with HSPs is essential. The objective of this paper was to study whether the main inducible heat shock proteins, HSP70 or HSP27, have a role in the overall sumoylation process and, more particularly, whether they could regulate HSF1 sumoylation. We found that HSP27, in the form of large oligomers, induced HSF1 SUMO-2/3 modification and blocked its transactivation capacity. By doing so, HSP27 allows a fast and precise modulation of HSP gene transcription, including that of its own gene.
Results and Discussion

HSP27 favours HSF1 modification by SUMO-2/3
To explore whether the two main stress-inducible HSPs, HSP27 and HSP70, play a role in the sumoylation process, we assessed their effect on HSF1 modification by SUMO-2/3. To this aim, we transiently transfected HeLa cells with a vector for either Myc-tagged wild-type HSF1 (HSF1-wt) or a non-sumoylable HSF1 mutant in which K298 has been replaced by arginine (HSF1-K298R), in the presence or in the absence of vectors for haemagglutinin (HA)-tagged HSP27 (HSP27) or HSP70 (HSP70) (Figure 1a ). SUMO-2/3 modification being inducible by stress (Saitoh and Hinchey, 2000) , therefore, the absence of detection of HSF1 modified by SUMO-2/3 was not surprising under our experimental conditions. The only exception for HSF1-SUMO-2/3 detection was in cells overexpressing HSP27 and HSF1-wt, as shown in Figure 1a , left panel, and confirmed on the right panel by reversing the immunoprecipitation/ immunodetection. As expected, this SUMO-2/3 modification of HSF1 induced by HSP27 disappeared in cells overexpressing the non-sumoylatable HSF1 mutant HSF1-K298R (Figure 1a) . Therefore, overexpression of HSP27 favours HSF1 modification by SUMO-2/3 on lysine 298 that, as shown in Figure 1a , could not be performed by an overexpression of HSP70. It should be noted that the shift observed in the size of HSF1 after modification by SUMO-2/3 is considerably higher than the calculated molecular mass of a SUMO molecule (11 kDa). This is consistent with previous studies, the explanation given being that conjugation of SUMO in the central region of HSF1 forms a branched protein structure responsible for aberrant electrophoretic migration (Hietakangas et al., 2003 2006), we also tested whether HSP27 could facilitate its sumoylation. We found that c-Fos modification by SUMO-2/3 in contrast to that of HSF1 was not affected by HSP27 (Figure 1b) . This indicated some substrate selectivity in the action of HSP27.
Thus, in the absence of stress other than the cell transfection per se, HSP27 can induce SUMO-2/3 modification of HSF1 but not of c-Fos. The fact that HSP27 depletion by means of a small interfering RNA (siRNA) decreases HSF1 modification by SUMO-2/3 induced by stress (that is, serum depletion for 48 h, Figure 1c ) further confirms a role for HSP27 in protein sumoylation.
HSP27 increases general protein sumoylation in cells
We next analysed whether HSP27 or HSP70 affected the general profile of proteins modified by SUMO-2/3. Mouse embryonic fibroblasts ( Figure 2a ) and HeLa cells (not shown) were transiently transfected with HSP27-HA or HSP70-HA expression vectors, and we favoured SUMO-2/3 modification by stress (48-h serum depletion, Figure 2a , or 100 nM staurosporine for 24 h, not shown). After denaturing cell lysis followed by immunoblotting analysis with antibodies against SUMO-2/3, the signal intensity of the sumoylated proteins profile was stronger in HSP27-overexpressing cells compared with control-transfected cells. In contrast, HSP70 HSP27 facilitates HSF1 sumoylation M Brunet Simioni et al overexpression did not alter the amount of protein modified by SUMO-2/3 ( Figure 2a ). As cell transfection is an artificial way to obtain an accumulation of HSPs, we induced the overexpression of endogenous HSPs by heat shock and studied the repercussion in the total cellular amount of proteins modified by SUMO-2/3. HeLa cells were exposed to 42 1C for 1 h and then cultured at 37 1C for different times to allow HSP expression. As expected, HSP70 was early induced reaching a peak 30 min-1 h after the heat shock and, by 2 h HSP70 level decreased ( Figure 2b ). In contrast, HSP27, a late inducible HSP, accumulated in the cells only at 6-12 h after the heat shock ( Figure 2b ). A heat shock also induced an increase in general protein modification by SUMO-2/3 and this increase was coincidental with HSP27 accumulation in the cells (Figure 2b ). Further, SUMO-2/3 modification induced by 48-h serum depletion was strongly decreased in HeLa cells in which HSP27 levels were depleted by means of a specific siRNA (Figure 2c ). Altogether, these results indicate that HSP27 can affect general protein sumoylation, whereas HSP70 cannot.
Large oligomers of HSP27 are needed to favour sumoylation Heat shock protein 27 (HSP27) has been shown to form oligomers of up to 1000 kDa. This oligomerization is modulated by the phosphorylation status of the protein, phosphorylation provoking a shift towards small oligomers. Accordingly, gel filtration experiments showed that an HSP27 mutant in which the three phosphorylable serines have been replaced by alanines (HSP27-Ala) abundantly yields large oligomers, whereas an HSP27 mutant in which the serine residues have been replaced by the phosphomimetic aspartates (HSP27-Asp) exclusively yields small oligomers (Lambert et al., 1999; Bruey et al., 2000; Parcellier et al., 2006) ( Figure 2d ). For these studies we used colon cancer REG cells stably transfected with the different HSP27 mutants because these cells do not express any detectable level of endogenous HSP27 (Bruey et al., 2000) ( Figure 2d ). Using the same experimental conditions as in Figure 1 , we found that although the HSP27-Ala mutant favoured overall SUMO-2/3 protein modification more efficiently than HSP27-wt, . This effect of HSP27 and HSP27-Ala favouring general protein sumoylation is specific for SUMO-2/3 as it does not concern SUMO-1 (Figure 2e , right panel). SUMO-1 is constitutively expressed, whereas SUMO-2/3 is induced by different stresses (Saitoh and Hinchey, 2000) . However, neither wild-type HSP27 nor its phosphorylation/oligomerization mutants modified the transcription level of the sumo-2/3 genes. (Supplementary Figure 1 and data not shown)
Next, in these same cells, we analysed the effect of the HSP27 phosphorylation/oligomerization mutants on HSF1 modification by SUMO-2/3. We observed that, although HSP27-Ala induced a more efficient sumoylation of HSF1 than HSP27-wt, the non-oligomerizing HSP27-Asp mutant was inefficient at inducing HSF1 SUMO-2/3 modification ( Figure 3a , left panel). Again, this modification specifically concerned SUMO-2/3 because HSP27 and HSP27-Ala did not alter the amount of HSF1 modified by SUMO-1 (Figure 3a , right panel). We conclude that HSP27, in the form of large oligomers, can affect the cellular content of proteins modified by SUMO-2/3 and that of HSF1 in particular.
To gain insight into the mechanism whereby HSP27 favours HSF1 modification by SUMO-2/3, we studied whether HSP27 could interact with the Ubc9 SUMO E2 enzyme. It has been previously shown that HSP27 can associate with Drosophila Ubc9 (Joanisse et al., 1998) and we confirmed this result for mammalian Ubc9. As shown in Figure 3b , wild-type HSP27 and HSP27-Ala associate with Ubc9, whereas HSP27-Asp, which is unable to induce SUMO-2/3 modification, did not interact with Ubc9. It is therefore possible that HSP27 might act as a scaffold to strengthen the interaction between Ubc9 and HSF1.
HSF1 and large oligomers of HSP27 associate Co-immunoprecipitation experiments carried out with an equal amount of antibody in HeLa cells (Figure 4a) showed that endogenous HSP27 can associate with HSF1. The interaction already observed in non-stressed cells increased after stresses inducing HSP27 expression HSP27 facilitates HSF1 sumoylation M Brunet Simioni et al such as staurosporine treatment (100 nM, for 24 h, not shown) or serum starvation for 48 h (Figure 4a ). To further characterize HSP27 and HSF1 interaction, we used REG cells transfected with a control vector or vectors for either HSP27-wt, HSP27-Ala or HSP27-Asp (Figure 4b ). Immunoprecipitation of endogenous HSF1 with the exogenously expressed HSP27 proteins showed that HSF1 interacted with HSP27-wt and HSP27-Ala mutant (Figure 4b) . Interestingly, the mutant HSP27-Asp, which is unable to form large oligomers and induce HSF1 sumoylation, did not interact with HSF1 ( Figure 4b ). The ability of large oligomers of HSP27 to interact with HSF1 was further studied by gel filtration analysis of extracts from HeLa cells either left untreated or serum depleted for 48 h both in order to increase HSP27 endogenous content and to induce SUMO-2/3 modification. A same amount of HSP27 was immunoprecipitated from the cell fractions obtained (though the HSP27 oligomerization status varied, as in Figure 2d ). Then, we determined by immunoblotting the amount of HSF1 in the precipitates. We observed that only the fractions corresponding to large multimers of HSP27 in the serum-depleted cell extracts contained SUMO-2/3-HSF1 (Figure 4c ). Here, it is interesting to note that HSF1 immunoprecipitated with the HSP27 antibodies exclusively showed an apparent molecular weight of 83 kDa (size of HSF1) with no detectable HSF1 at 175 kDa, which would correspond to HSF-1-SUMO-2/3 (Hietakangas et al., 2003 Figure 4 Heat shock protein 27 (HSP27) large oligomers associate to heat shock factor 1 (HSF1). (a) Immunoprecipitation (IP) carried out with an anti-HSP27 antibody was followed by immunodetection (western blot (WB)) of HSF1 in HeLa cells either untreated (NT) or stressed by 48-h serum depletion (SD). (b) Immunoprecipitation of HSF1 from control-, HSP27-wild type (wt)-, HSP27-Ala-or HSP27-Asp-transfected REG cells was followed by immunodetection of HSP27 in NT and SD cells). (c) HeLa cell extracts from NT and SD cells were fractionated through a Superose-6-column to separate the HSP27 oligomers by their size (as in Figure 2d ). After concentration of the cell fractions, extracts containing a same amount of HSP27 were immunoprecipitated with SUMO-2/3 and the presence of HSF1 was analysed by western blot.
HSP27 facilitates HSF1 sumoylation M Brunet Simioni et al sumoylated substrate once having played its sumoylation-promoting part.
Large oligomers of HSP27 and HSF1 colocalize in the nucleus with SUMO-2/3 Microscopic analysis of HSP27 and HSF1 cellular distribution before and after stress (48-h serum depletion) showed that although HSP27 was mainly cytosolic, HSF1 could be found both in the nucleus and cytosol (Figures 5a). After stress, HSP27 nuclear localization is greatly potentiated (Figure5a and inputs of Figure 5c ). The nuclear localization of HSP27 after stress was more evident in the case of HSP27-Ala (Figure 5a ). In contrast, HSP27-Asp, which only gives small oligomers, did not accumulate within the nucleus under the stress conditions used in this study (48-h serum depletion, Figure 5a and inputs of Figure 5c or staurosporine 100 nM, not shown). These results suggest that the formation of large oligomers is necessary either for HSP27 nuclear translocation or for its retention within the nucleus. The latter hypothesis seems more plausible as small oligomers of HSP27 although in small quantities can also be found in the nucleus (mutant HSP27-Asp, Figure 5a and inputs of Figure 5c ). Therefore, it is likely that large oligomers of HSP27 form within the nucleus (after import of either HSP27 monomers or small oligomers) and can no longer exit due to their size.
Heat shock factor 1 has already been reported to be found in the nucleus together with SUMO proteins (Hietakangas et al., 2003) . Here we found that after stress SUMO-2/3 strongly accumulates in the nucleus of HSP27-Ala-expressing cells or in the nucleus of cells expressing HSP27-wt (Figure 5b ). We therefore conclude that large oligomers of HSP27 accumulate in the nucleus together with HSF1 and SUMO-2/3.
To show that HSP27 and HSF1 associate within the nucleus where they accumulate with SUMO-2/3 under stress conditions, we carried out co-imunoprecipitations experiments using nuclear and cytosolic fractions from REG cells transfected with vectors for HSP27-wt, HSP27-Ala or HSP27-Asp (Figure 5c ). We detected no interaction between HSP27-wt and HSF1 in the nucleus of non-stressed cells. In contrast, a strong interaction could be detected in the nuclear fraction of serumdepleted cells (Figure 5c ). Similarly, a strong nuclear interaction was also observed in serum-depleted HSP27-Ala-expressing cells (data not shown). As expected, no interaction was observed in the HSP27-Asp fractions (Figure 5c ). In the non-stressed cells, a quantitatively less important interaction was observed in the cytosolic fractions from HSP27-wt-and HSP27-Alaexpressing cells (Figure5c and not shown) , but not from the HSP27-Asp-expressing cells (Figure 5c ). Thus, in non-stressed cells, the interaction with cytosolic (inactive) HSF1 also involves large oligomers of HSP27. Although we still do not know the function of this cytosolic interaction, it is tempting to speculate that HSP27 might help maintain HSF1 inert in non-stressed cells.
HSP27 inhibits HSF1 transcriptional factor activity without affecting upstream HSF1 activation steps We next studied whether HSP27 affected hsf1 gene transcription and/or the abundance of the HSF1 protein. Neither HSP27-wt nor its mutants HSP27-Ala or HSP27-Asp affected the transcription level of the hsf1 gene (Supplementary Figure 2) . At the protein level, HSF1 content was the same in cells either overexpressing HSP27 or in those where HSP27 was depleted by means of a specific siRNA (Supplementary Figure 3a) . Furthermore, the amount of HSF1 was the same in cells expressing HSP27-wt or in the mutants, HSP27-Ala and HSP27-Asp (Supplementary Figure 3b) . Altogether, these results indicate that the effect of HSP27 on HSF1 seems to be exclusively at the post-translational level.
Heat shock factor 1 phosphorylation on S303 is needed for HSF1 sumoylation and for its nuclear co-localization with SUMO (Hietakangas et al., 2003) . Therefore, we tested whether the HSP27 effect on HSF1 sumoylation is the result of an increase in the phosphorylation of HSF1 on S303. To study this, we used an antibody specifically recognizing phosphorylated S303 and S307 (Hietakangas et al., 2003) . The amount of HSF1 phosphorylated on S303 and S307 was compared in control-transfected REG cells and REG cells expressing either HSP27-wt or HSP27-Ala (Figure 6a ). We found that the amount of HSF1 phosphorylated on these serine residues was the same in all transfected cells, even though only those expressing HSP27-wt and HSP27-Ala had an increase in the content of HSF1 modified by SUMO-2/3. This result suggests that HSP27 favours HSF1 sumoylation downstream of these phosphorylation events.
Heat shock factor 1 DNA-binding and transactivation activities have been shown to be regulated independently . We therefore first wondered whether HSP27-induced modification of HSF1 by SUMO-2/3 could affect HSF1 DNA-binding activity. Binding of HSF1 to DNA was studied by means of a pull-down approach . In this experiment, we used biotinylated doublestranded oligonucleotides containing the consensus HSE as bait. As shown in Figure 6b , HSF1 was equally pulled down whether extracts were from REG-stressed (serum-depleted) control-transfected cells, or from HSP27-wt-, HSP-27-Ala-or HSP27-Asp-transfected cells. These results suggest that HSP27 does not affect HSF1 DNA-binding ability. This is in accordance with previous results showing that modification by SUMO did not significantly alter HSF1 DNA binding .
We next examined whether HSP27 could affect HSF1 transcription factor activity. REG cells were transfected with either a control empty vector or vectors for HSP27-wt, HSP27-Ala or HSP27-Asp. These transfections were carried out together with wild-type HSF1 or the sumoylation-deficient HSF1-K298R mutant and a luciferase reporter plasmid containing the proximal HSE of human hsp70 promoter. The transfection per se was enough stress to induce HSF1 transactivation HSP27 facilitates HSF1 sumoylation M Brunet Simioni et al activity in control cells (transfected with an empty vector, a luciferase reporter vector and either HSF1-wt or HSF1-K298R). HSF1 activity was increased when the cells were submitted to further stress (serum depletion, Figure 7 ). These levels of transcriptional activity were not significantly altered in the cells expressing non-sumoylatable HSF1-K298R, indicating that under these experimental conditions (low HSP27 levels) sumoylation did not significantly regulate HSF1 transcriptional factor activity. In contrast, under conditions of expression of large oligomers of HSP27 (in cells transfected with HSP27-wt and, still more, in cells transfected with the HSP27-Ala mutant), HSF1 transcriptional activity was strongly reduced (Figure 7) . The effect of HSP27-wt and HSP27-Ala decreasing HSF1 transcription factor activity was lost when we expressed the HSF1 sumoylation mutant HSF1-K298R (Figure 7 ). This shows that the regulation of HSF1 transcription activity by HSP27 involves the sumoylation of the transcription factor. The expression of the HSP27-Asp mutant did not have any measurable action in HSF1 transcription factor activity (Figure 7) , again showing the absence of effect for the small multimers of HSP27. Altogether, these results indicate that accumulation in the nucleus of large oligomers of HSP27 induces an increase in HSF1 modification by SUMO-2/3, which results in a decrease in its transactivating capacity. This allows HSP27 to regulate its own content in the cells with a negative feedback mechanism and to control the stress response (Figure 8 ). The kinetics of HSF1 sumoylation and that of HSP27 accumulation after stress like heat shock confirm this model (Supplementary Figure 4 ).
Concluding remarks
After stress, cells transiently express HSPs in a precise and coordinated manner: first, the early inducible HSPs such as HSP70 and HSP90 and, then, the late inducible ones like HSP27. HSPs, by tightly controlling their own production at different levels, can act as sensors to determine the intensity and duration of the stress response. HSP70 and HSP90 have already been reported to control HSF1 activation. In non-stressed cells, HSP70 and HSP90 bind to monomeric HSF1 and render it inert in the cytosol (Shi et al., 1998; Voellmy and Boellmann, 2007) . During attenuation of the stress response, the transcriptional activity of HSF1 is repressed by direct binding of HSP70 and HSP90 to the HSF1 transactivation domain (Shi et al., 1998; Voellmy and Boellmann, 2007) . Here, we show for the first time the involvement of a heat shock protein in the sumoylation process and particularly in HSF1 modification by SUMO-2/3. HSP27, in the form of large oligomers, by inducing HSF1 sumoylation also regulates the stress response (Figure 8 ). Immediately after stress, it has been reported that HSP27 is transiently phosphorylated, which results in a shift towards small oligomers (Mehlen et al., 1995a) that, as it is shown in this study, are unable to induce SUMO-2/3 modification of HSF1. As a consequence, HSP27 is freely transcribed right after stress. Later on, likely when the amount of HSPs in general, and that of HSP27 in particular, is sufficiently high, HSP27 is de-phosphorylated (Mehlen et al., 1995b) and re-forms large oligomers. As shown here, these large forms of HSP27 accumulate within the nucleus, bind to HSF1 and favour its modification by SUMO-2/3, which ultimately blocks the transcription of HSP genes Heat shock protein 27 (HSP27) expression does not affect heat shock factor 1 (HSF1) phosphorylation or DNA-binding ability. (a) HSF1 was immunoprecipitated in non-treated (NT) or 48-h serum-depleted (SD) REG cells control (Co) or expressing HSP27-wild type (wt) or HSP27-Ala. The amount of HSF1 phosphorylated in S303 or S307 in the precipitates was determined. (b) Extracts from 48-h serum-depleted REG cells expressing either a control vector (Co) or a vector for HSP27-wt, HSP27-Ala or HSP27-Asp were incubated with biotinylated double-stranded oligonucleotide containing the consensus heat shock element as bait. The amount of precipitated HSF1 after pull-down was immunodetected (BOUND). Scr, scrambled.
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M Brunet Simioni et al (Figure 8 ). However, it should be noted that, although less important, we can detect an interaction between cytosolic HSF1 and large oligomers of HSP27 under non-stressed conditions. This interaction should not result in increased HSF1 sumoylation as phosphorylation on S303, needed for HSF1 nuclear localization and activation, is required for HSP27 to induce HSF1 modification by SUMO-2/3. HSP27 might bind to inactive cytosolic HSF1 to maintain it inert, as it does for HSP70 or HSP90 (Shi et al., 1998; Voellmy and Boellmann, 2007) . SUMO conjugation utilizes a multistep enzymatic pathway, in which proteolytically processed SUMO initially forms a thioester bond with Sae1/2, the E1 SUMO-activating enzyme (Johnson, 2004) . The SUMO moiety is subsequently transferred to Ubc9, the single E2 SUMO-conjugating enzyme, which usually binds directly to the target protein at the level of sumoylated sites (Geiss-Friedlander and Melchior, 2007) . Although the enzymatic activity required for substrate modification can be carried out by the E1 and E2 enzymes alone , the E2-substrate interaction may be facilitated by SUMO E3 factors. The E3 factors increase sumoylation efficiency in a substrate-specific manner, either by accelerating the transfer of SUMO from Ubc9 to the substrate or merely by providing a scaffold (Johnson, 2004) . Therefore, our data raise the interesting possibility that the chaperone HSP27 might Figure 8 Scheme representing how heat shock protein 27 (HSP27) may affect heat shock factor 1 (HSF1) activity. Under conditions of increased HSP27 expression (that is stress conditions), large oligomers of HSP27 accumulates in the nucleus. Most probably, these large multimers of HSP27 form within the nucleus after the import of small oligomers of HSP27 and are temporary trapped because of their size. Nuclear large oligomers of HSP27 interact with HSF1. This interaction favours HSF1 sumoylation by SUMO-2/3. As a result, HSF1 transcription factor activity is impaired. Therefore, HSP27 can modulate its own production with a feedback mechanism.
HSP27 facilitates HSF1 sumoylation M Brunet Simioni et al be an E3 factor as it facilitates HSF1 modification by SUMO-2/3 with some specificity (as HSP27 does not affect sumoylation of a protein like c-Fos). The fact that HSP27 binds to mammalian Ubc9 (this paper) and to Drosophila Ubc9 (Joanisse et al., 1998) further suggests that HSP27 may act like an E3 SUMO protein to permit stronger interaction between Ubc9 and HSF1. Another interesting observation of this study is the fact that HSP27 concerns modification by SUMO-2/3 but not that by SUMO-1. The mammalian SUMO protein family includes four members, of which only SUMO-2/3 are conjugated in a stress-dependent manner. A recent report in which the authors used a proteomic approach to determine the proteins modified by SUMO-2/3 shows that most targets do not contain a consensus sumoylation site (Blomster et al., 2009) . Stress-inducible chaperones might be involved in this consensus siteindependent recognition mechanism of SUMO-2/3.
A tight regulation of inducible HSP expression is essential as an abnormal accumulation of these proteins can have pathological consequences. Clinical and experimental studies have showed that a constitutive accumulation of inducible HSPs (mainly HSP27 or HSP70) is associated with a poor prognosis and an increase in the tumorigenic and metastatic potential of tumour cells (Jaattela, 1995; Garrido et al., 1998; Bruey et al., 2000; Gurbuxani et al., 2001; Westerheide et al., 2006; Didelot et al., 2007) . It would be interesting to determine whether defaults in the modulation of HSF1 sumoylation by HSP27 are involved in this abnormally high HSPs expression characteristic of cancer cells.
Materials and methods
Cell culture and treatment HeLa cells were cultured in Dulbecco's modified Eagle's medium (Sigma, St Quentin, Fallavier, France) containing 10% fetal calf serum (FCS). REG cells were grown in Ham's F-10 medium (Sigma) supplemented with 10% FCS (Caignard et al., 1990) . staurosporine was purchased from Sigma.
Transfections, plasmids and siRNA REG cells stably transfected with HSP27 phosphorylation mutants were already described (Bruey et al., 2000) . pcDNA 3 -HA-HSP27-wt plasmid codes for wild-type HA-tagged HSP27. pcDNA 3 -HA-HSP27-Ala and pcDNA 3 -HA-HSP27-Asp correspond to the substitutions of HSP27 serine residues (serines 15, 78 and 82) by alanine or aspartate, respectively (provided by M Gaestel, Hannover Medical School, Germany). HSP27 siRNA (5 0 -AAAATCCGATGAGACTGCCGC-3 0 ) and luciferase siRNA (5 0 -AACTTACGCTGAGTACTTCGATT-3 0 ) were purchased from Ambion (Applied Biosystems, Courtaboeuf, France). Transfections were carried out following the manufacturer's instructions with jetPEI reagent (Ozyme, St Quentin Yvelines, France) or Interferine (Ozyme) for siRNA.
Cell fractionation
Nuclear extracts were prepared from 10 6 cells carefully resuspended in 800 ml of buffer I (Tris 10 mM pH7.4; NaCl 10 mM; MgCl 2 3 mM; phenylmethylsulphonyl fluoride 0.5 mM; dithiothreitol 2 mM) and incubated on ice for 10 min. Then 0.2% NP40 was added. Each sample was homogenized by inversion and incubated on ice for 2 min. Cell lysate was centrifuged for 4 min at 400 g. The pellet was washed another time in 1 ml buffer I, centrifuged for 4 min at 400 g. The pellet was recovered in buffer II (Tris 20 mM pH7.4; Na 4 P 2 O 7 40 mM; MgCl 2 5 mM; NaF 50 mM; Na 3 VO 4 100 mM; EDTA 10 mM; Triton 1%, SDS 1%), sonicated and centrifuged for 10 min at 20 000 g. The supernatant was kept and immunoprecipitation experiments were carried out as described below.
For cytoplasmic extracts, 10 6 cells were carefully resuspended in 400 ml of buffer I (Tris 10 mM pH7.4, NaCl 10 mM, MgCl 2 3 mM, phenylmethylsulphonyl fluoride 0.5 mM, dithiothreitol 2 mM) and incubated on ice for 10 min. Then 0.2% NP40 were added, Each sample was homogenized by returnment and incubated on ice for 2 min. Cell lysate was centrifuged for 2 min at 10 000 g. The supernatant was centrifuged another time for 2 min at 10 000 g and immunoprecipitation experiments were carried out as described above.
Immunoprecipitation Cellular proteins were extracted using immunoprecipitation buffer (50 mM HEPES pH 7.6; 150 mM NaCl; 5 mM EDTA; 0.1% Nonidet P-40 (NP-40), 20 mM N-ethyl maleimide). In all, 500 mg of proteins were incubated with 4 mg of the indicated antibody (anti-green fluorescent protein, anti-HSF1 and anti-HSP27 (TebuBio, Le Perray en Yvelines, France), anti-SUMO-2/3 and anti-SUMO-1 (Cell Signaling, St Quentin en Yvelines, France)) with constant agitation at 4 1C overnight. Then, immunocomplexes were precipitated with protein A/GSepharose (GE Healthcare, Orsay, France).
Immunoblotting
Cell were lysed in RIPA buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 0.5% sodium deoxycholate, 0.1% SDS, 1% NP40, protease inhibitor cocktail (Roche, Fontenay, France) and 20 mM N-ethyl maleimide) or in immunoprecipitation buffer. In all, 10-40 mg proteins were used for immunoblotting with the following antibodies: anti-HSP27, -HSP70, -HSF1 (TebuBio), -S303/7-phospho-HSF1 (kind gift of L Sistonen (Hietakangas et al., 2003) ), -SUMO-2/3, -SUMO-1 (Cell Signaling) and -HSC70 (Santa Cruz, Tebu Bio, Le Perray en Yvelines, France).
Gel filtration
Cells were lysed in gel filtration buffer (25 mM HEPES pH 7.5, dithiothreitol 0.2 mM, CHAPS 1% and 20 mM N-ethyl maleimide). One mg protein of the supernatant was fractionated by fast protein liquid chromatography using a Superose-6 column (Pharmacia, Uppsala, Sweden) at a flow rate of 0.3 ml/min. Fractions of 1 ml were collected on ice and concentrated using Amicon Ultra (Millipore, Saint Quentin en Yvelines, France).
Immunofluorescence staining Cells were fixed with 4% phosphate-buffered saline (PBS)-paraformaldehyde and permeabilized by incubation with 3% PBS-Triton X-100. After washing with PBS, samples were saturated with 3% PBS-bovine serum albumin (BSA) before overnight incubation at 4 1C with HSP27, HSF1 or SUMO-2/3 antibodies. After washes with 1% PBS-BSA, appropriate secondary antibodies coupled with fluorochromes (Alexa 486 nm and 568 nm; Molecular Probe, Leiden, the Netherland) were added. The nucleus was labelled with Hoechst 33342. Images were acquired using the Cell Observer Station (Zeiss, Le Pecq, France).
Oligonucleotide pull-down assay
In all, 300 mg of cell lysates containing 40 mM N-ethylmaleimide were incubated with 0.5 mM annealed oligonucleotide in binding buffer (20 mM Tris-HCl pH 7.5, 100 mM NaCl, 2 mM EDTA, 10% glycerol). Salmon sperm DNA was added (0.5 mg/ ml), and proteins were allowed to bind to the oligonucleotides for 30 min at room temperature. Samples were pre-cleared with CL-4B Sepharose (Sigma) for 30 min at 4 1C, and the remaining DNA was precipitated with 15 ml of 50% slurry of UltraLink streptavidin gel (Pierce, Rockford, IL, USA) for 1 h at 4 1C. After washing, DNA-bound proteins were eluted with denaturing buffer, followed by SDS-polyacrylamide gel electrophoresis and immunoblotting using a polyclonal HSF1 antibody. The HSE-containing oligonucleotides used were: 5 0 -biotin-AACGAGAATCTTCGAGAATGGCT-3 0 and 5 0 -AGCCATTCTCGAAGATTCTCGTT-3 0 , and the corresponding scrambled control oligonucleotides 5 0 -biotin-AAC GACGGTCGCTCCGCCTGGCT-3 0 and 5 0 -AGCCAGGCG GAGCGACCGTCGTT-3 0 (Invitrogen, Cergy Pontoise, France).
Luciferase reporter assays
Cells were harvested at 24 h after transfection and assayed using Promega's Luciferase Assay System (Promega, Charbonnieres, France). Cells were washed once in PBS, scraped into 100 ml of reporter lysis buffer and rocked 15 min at 4 1C. A total of 20 ml of cell lysates were combined with 100 ml assay reagent and luciferase activity was measured using a luminometer (LUMAT LB 9507, Berthold Technologies, Thoiry, France). To normalize for transfection efficiency, the activity of co-transfected b-galactosidase was also assayed. In all, 20 ml of cell lysates were combined with 100 ml of lysis buffer and 100 ml of 2Â b-galactosidase assay buffer. Samples were incubated at 37 1C for 30 min. The reaction was terminated by the addition of 1 M of Na 2 CO 3 and the absorbance at 420 nm was recorded.
Reverse transcriptase-PCR analysis RNA extraction was carried out with the Nucleospin RNA II kit (Macherey-Nagel, Hoerd, France), and the OneStep reverse transcriptase-PCR kit (Qiagen, Courtaboeuf, France) was used according to the manufacturer's instructions, and the following specific primers for the hsf1 gene (forward, 5 0 -GGTCAAGCCAGAGAGAGACG-3 0 ; reverse, 5 0 -CTCAT GCTTCATGGCCAGGA-3 0 ), the sumo-2 gene (forward, 5 0 -GAAAAGCCCAAGGAAGGAGT-3 0 ; reverse, 5 0 -GTCT GCTGTTGGAACACATCA-3 0 ) with the human hprt gene as a control (forward, 5 0 -GGACAGGACTGAACGTCTTGC-3 0 ; reverse, 5 0 -CTTGAGCACACAGAGGGCTACA-3 0 ).
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